NCT03278704

Brief Summary

It is recommended that individuals perform a combination of resistance exercise (RE) and endurance exercise. Lack of time is often cited as a reason for being unable to meet current exercise guidelines. Therefore, combining both forms in one session may be beneficial. However, research continues to elucidate whether interference of adaptive outcomes occurs when RE and endurance exercise are performed concurrently. A proposed interference effect suggests that concurrent training may dampen RE-induced adaptations (e.g., muscle strength and growth) compared to RE only. The propose of this investigation is to determine the effects of concurrent RE and high-intensity interval training (HIIT), compared to RE only, on muscle health and cardiovascular risk in sedentary, middle-aged (40-65 years) who are overweight/obese with type 2 diabetes mellitus (T2DM). The investigators will measure the effects on muscle strength, muscle growth, cardiovascular fitness, glycaemic control and markers of cardiovascular risk before and after an 8-week training program. Data will be obtained through the analysis of skeletal muscle samples, blood samples, magnetic resonance imaging, questionnaires and exercise performance tests.It is hypothesized that concurrent RE + HIIT will amplify the exercise-induced muscle growth response, which will result in greater satellite cell content, compared to RE alone. As a result, this will lead to greater skeletal muscle mass and strength after RE + HIIT compared to RE in isolation. A finding that concurrent resistance training and HIIT does not impede muscle adaptations could offer future strategies to minimize exercise time commitment whilst still maximizing the physiological benefits of both resistance and endurance exercise through a single training session. This may therefore provide an effective exercise strategy in the prevention and/or treatment of T2DM.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Dec 2017

Shorter than P25 for not_applicable type-2-diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 12, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

December 6, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2018

Completed
Last Updated

July 17, 2018

Status Verified

July 1, 2018

Enrollment Period

7 months

First QC Date

September 4, 2017

Last Update Submit

July 13, 2018

Conditions

Keywords

Concurrent trainingType 2 Diabetes MellitusResistance exerciseHigh-Intensity Interval Training (HIIT)Muscle hypertrophyInterference effect

Outcome Measures

Primary Outcomes (1)

  • Change in fibre-type specific satellite cell content

    Assessed using immunofluorescence microscopy (Pax7-positive cells)

    Prior to the 8-week training intervention and 72 hours after the last training session

Secondary Outcomes (9)

  • Change in muscle-specific gene expression related to growth adaptations

    Prior to the 8-week training intervention and 72 hours after the last training session

  • Change in muscle fibre size

    Prior to the 8-week training intervention and 72 hours after the last training session

  • Change in muscle size

    Prior to the 8-week training intervention and 48 hours after the last training session

  • Change in isometric muscle strength

    Prior to the 8-week training intervention and 6 days after the last training session

  • Change in isokinetic muscle strength

    Prior to the 8-week training intervention and 6 days after the last training session

  • +4 more secondary outcomes

Study Arms (2)

RE training only

OTHER

RE only - Progressive resistance exercise training only (leg extension, leg step up, chest press and pull down).

Other: RE only

Concurrent RE + HIIT

EXPERIMENTAL

RE + HIIT - Progressive resistance exercise training (leg extension, leg step up, chest press and pull down) followed by HIIT (10 x 1 min at 90% heart rate maximum).

Other: RE + HIIT

Interventions

RE onlyOTHER

8 weeks of supervised training. Three times weekly with no more than two non-consecutive days without exercise.

RE training only

8 weeks of supervised training. Three times weekly with no more than two non-consecutive days without exercise. Concurrent training: RE followed by HIIT within the same session.

Concurrent RE + HIIT

Eligibility Criteria

Age40 Years - 65 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male sex
  • White British/European
  • Aged between 40 and 65 years at the time of screening
  • Have a body mass index (BMI; body weight/height in m2) between 27 and 40 kg/m2
  • Sedentary/untrained for at least 1 year (based on physical activity self-reports of fewer than two sessions of structured exercise per week last \<30 min)
  • T2DM (American Diabetes Association 2014) for more than 1 year
  • Central obesity (defined as waist circumference ≥94 cm for males)

You may not qualify if:

  • Currently involved in research or have recently (\<6 months) been involved in any research prior to recruitment
  • Any condition limiting or contraindicating physical activity; including diabetic peripheral neuropathy, and coronary or peripheral artery disease
  • Previous myocardial infarction, previous or current angina, shortness of breath, or other symptoms suggestive of heart failure
  • Insulin medication
  • HbA1c more than 75 mmol/mol (9%)
  • Uncontrollable hypertension: systolic blood pressure ≥160 mmHg and diastolic blood pressure ≥100 mmHg
  • Not weight stable for the last three months
  • Smokers (within the last 12 months)
  • Anticoagulant medication, such as warfarin or newer anticoagulant drugs. If participants are on aspirin medication, this would need to be stopped for 3 days prior to and during the day of any biopsy visit unless contraindicated (in which case participants would be excluded).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham

Birmingham, B15 2TT, United Kingdom

Location

Related Publications (2)

  • American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014 Jan;37 Suppl 1:S14-80. doi: 10.2337/dc14-S014. No abstract available.

    PMID: 24357209BACKGROUND
  • Babcock L, Escano M, D'Lugos A, Todd K, Murach K, Luden N. Concurrent aerobic exercise interferes with the satellite cell response to acute resistance exercise. Am J Physiol Regul Integr Comp Physiol. 2012 Jun 15;302(12):R1458-65. doi: 10.1152/ajpregu.00035.2012. Epub 2012 Apr 4.

    PMID: 22492813BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Professor M Nimmo, PhD

    University of Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: This is an exploratory randomized controlled trial. Participants will complete a parallel designed study, in which they will be randomly assigned to a resistance exercise (RE) only or concurrent RE and high-intensity interval training (RE + HIIT) group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2017

First Posted

September 12, 2017

Study Start

December 6, 2017

Primary Completion

July 12, 2018

Study Completion

July 12, 2018

Last Updated

July 17, 2018

Record last verified: 2018-07

Locations